Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.2900
-0.0038 (-1.29%)
At close: Aug 13, 2025, 4:00 PM
0.2820
-0.0080 (-2.76%)
Pre-market: Aug 14, 2025, 9:05 AM EDT
INTS's stock price has decreased by -93.38% in the past year and price targets may not have had time to catch up.
Intensity Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$5.50
Upside
+1,796.55%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $3 | Hold → Strong Buy | Upgrades | $3 | +934.48% | Aug 12, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +2,831.03% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,624.14% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +1,624.14% | Oct 31, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +4,037.93% | Jul 11, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +4,037.93% | May 16, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +4,037.93% | Mar 21, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +4,037.93% | Nov 14, 2023 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +4,037.93% | Aug 24, 2023 |
| Benchmark | Benchmark | Buy Initiates $12 | Buy | Initiates | $12 | +4,037.93% | Jul 18, 2023 |